
Inappropriate imaging for low-risk prostate cancer and low-risk breast cancer varies by region.

Inappropriate imaging for low-risk prostate cancer and low-risk breast cancer varies by region.

CMS released their final decision for lung cancer screening with low-dose CT.

NCCN Group 2 high-risk patients to benefit from CT lung screening, study says.

Patients who underwent low-dose CT for lung cancer screening and received false-positives benefited from counseling.

Low-dose CT lung cancer screening detects more early cancers in at-risk patients than radiography, but with lower positive predictive value.